Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.4568
+0.0178 (4.05%)
At close: Apr 23, 2025, 4:00 PM
0.3805
-0.0763 (-16.70%)
Pre-market: Apr 24, 2025, 4:29 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $2.02 million as of April 24, 2025. Its market cap has decreased by -84.67% in one year.
Market Cap
2.02M
Enterprise Value
1.39M
1-Year Change
-84.67%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $2.02M, a decrease of -99.37%. That is a compound annual growth rate of -77.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 1.94M | -79.19% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |